Clinical efficacy of Vortioxetine and escitalopram in the treatment of depression

OBJECTIVES: This study was aimed to investigate the efficacy and safety of vortioxetine hydrobromide in the treatment of major depressive disorder (MDD). METHODS: One hundred and eighty patients with the newly diagnosed depression in our hospital between August 2018 and August 2019 were selected and...

Descripción completa

Detalles Bibliográficos
Autores principales: Shao, Shichuan, Sun, Baomin, Sun, Huiqing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Professional Medical Publications 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9247771/
https://www.ncbi.nlm.nih.gov/pubmed/35799757
http://dx.doi.org/10.12669/pjms.38.5.5230

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9247771/
https://www.ncbi.nlm.nih.gov/pubmed/35799757
http://dx.doi.org/10.12669/pjms.38.5.5230

Ejemplares similares